Literature DB >> 33354471

Acinetobacter Baumannii Native Valve Infective Endocarditis: A Case Report.

Ismahane Lahmidi1, Darar Charmake2, Noha Elouafi2, Zakaria Bazid2.   

Abstract

Infective endocarditis caused by Acinetobacter (A.) baumannii is a rare but severe complication that affects seriously ill, hospitalized patients undergoing invasive procedures. It is associated with an increased mortality rate than that of endocarditis due to the HACEK group (Haemophilus species, Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae) gram-negative bacteria. We report a case of a 54-year-old woman who was diagnosed with infective endocarditis caused by A. baumannii three days following her admission to the intensive unit care (ICU). The diagnosis was made on the basis of repeated blood cultures and transthoracic echocardiography, which revealed mobile vegetation attached to the mitral valve. In spite of aggressive therapeutic regimens, outcomes were poor and the patient died. This report underlines the severe nature of A. baumannii infections, which are still associated with a prolonged hospital stay, and increased morbidity, mortality, and medical costs.
Copyright © 2020, Lahmidi et al.

Entities:  

Keywords:  acinetobacter baumannii; infective endocarditis; nosocomial infections

Year:  2020        PMID: 33354471      PMCID: PMC7746322          DOI: 10.7759/cureus.11527

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Infective endocarditis (IE) is a life-threatening infection involving the endocardial surface of the heart. Although uncommon, IE has a high mortality rate, even with appropriate antibiotic therapy and surgical intervention. Gram-positive cocci, mostly Staphylococcus aureus and Streptococci, are the main causes of infective endocarditis. Gram-negative bacteria and fungi are not frequent pathogens of infective endocarditis [1-2]. Acinetobacter (A.) species are ubiquitous gram-negative coccobacilli and usually cause nosocomial infections, principally ventilator-associated pneumonia and catheter-associated bacteremia, as well as soft tissue and urinary tract infections. Community-acquired infections by Acinetobacter baumannii are increasingly reported [3]. A rare case of native mitral valve endocarditis secondary to A. baumannii is described in the present report.

Case presentation

A 54-year-old woman presented with a month-long history of painful necrotic ulcer in the left second toe, resistant to conventional treatment. She developed severe sepsis requiring admission to the intensive care unit. On her third day of hospitalization. she developed a high fever of 39.5°C. A new mitral systolic murmur (3/6 intensity) was noted on auscultation. Because of the high suspicion of infective endocarditis, transthoracic echocardiography (TTE) was carried out, which showed mobile vegetation measuring 0.2 × 0.8 cm attached to the mitral valve (Figure 1). A diagnosis of native mitral valve infective endocarditis was established according to the Duke criteria [4]. The patient subsequently was transferred to the cardiac care unit after hemodynamic stabilization. Upon arrival in our unit (cardiac care unit), the patient’s clinical examination revealed a temperature of 39.8°C, blood pressure (BP) of 110/60 mmHg, sinus tachycardia with a pulse of 100/min, and respiratory rate of 20/minute, with an oxygen saturation of 98% on room air. Cardiovascular examination revealed no signs of heart failure, a mitral systolic murmur was heard, and no peripheral stigmata of infective endocarditis were observed. There was a black ischemic ulcer on the dorsum of the left second toe, with oedema (Figure 2). Foul-smelling purulent drainage was noted on her toe ulcer. A dermatology consult was requested for skin ulcer biopsy and culture, a skin punch biopsy of her left second toe ulcer was obtained. Cultures of these skin biopsies grew Staphylococcus aureus and Candida parapsilosis but failed to isolate Acinetobacter baumannii. Histopathology of his skin biopsy reported leukocytoclastic vasculitis. Three blood cultures were carried out at an interval of an hour, as she had a high temperature (40°C); another blood sample was also collected. Two sets of blood cultures yielded Acinetobacter baumannii. The antibiotic susceptibilities of the A. baumannii isolated from our patient are summarized in Table 1.
Figure 1

Transthoracic echocardiography showed 0.8 × 0.2 cm vegetation on the patient’s mitral valve in the parasternal long-axis view

Figure 2

Necrotic ulcer of the patient’s second left toe

Table 1

Antibiotic susceptibility profile of Acinetobacter baumannii isolated from our patient

AntibioticSusceptibility
PiperacillinResistant
Piperacillin-tazobactamResistant
TicarcillinResistant
Ticarcillin-clavulanateResistant
CefotaximeResistant
CeftriaxoneResistant
CeftazidimeResistant
ImipenemResistant
CiprofloxacinResistant
LevofloxacinResistant
AmikacinSusceptible
GentamicinResistant
TobramycinResistant
TetracyclineIntermediate
DoxycyclineSusceptible
Trimethoprim/sulfamethoxazoleSusceptible
Laboratory test results revealed an elevated C-reactive protein (CRP) (100 mg/L) and erythrocyte sedimentation rate (ESR) (110 mm/hour). We also noted leukocytosis (white blood cell count 22,000 cells/mm3, 80% neutrophils) and normochromic normocytic anaemia. Liver function, serum creatinine levels, and the extracted urine sample were normal. Initially, vancomycin, gentamycin, and fluconazole were started but intermittent fever and chills persisted. After blood culture results, polymyxin E was set for 45 days without clinical improvement. Abdominopelvic computed tomography (CT) did not show any abnormalities. Antibiotics were shifted to tigecycline, and early surgical intervention was considered. However, the patient was medically not fit for cardiac surgery with multi-organ failure, and she subsequently died.

Discussion

A. baumannii is a ubiquitous bacterial pathogen that is largely implicated in nosocomial infections. It is a pleomorphic, aerobic gram-negative bacillus, non-motile, and widely distributed in the environment. Its ability to survive even in hostile conditions allows it a wide circulation in the hospital setting. It is often spread to patients from workers’ hands or healthcare devices [5]. There are many risk factors associated with Acinetobacter spp. bacteremia-like invasive procedures, mechanical ventilation, and surgery [6]. Among 17 cases of A. baumannii endocarditis reviewed [7], the inciting events were dental work, intravenous drug abuse, septic abortion, stab wounds, burns, intravenous catheters, and open-heart surgery. None of these events was noted in our patient except for the hemodialysis catheter in his right internal jugular vein. Most likely, in our patient, the infection is secondary to invasive procedures (intravascular catheter). We postulated also that the skin lesions (left second toe ulcer) could be the likely nidus of the infection. The most frequent sites of infection are urinary and respiratory tracts, bloodstream, and surgical sites. A few cases of A. baumannii endocarditis have previously been reported. Prosthetic valves were involved in the majority of these cases [8-9]. Native valve endocarditis due to A. baumannii is a life-threatening infection, with a worse prognosis than the prosthetic valve form, perhaps because of the poor index of suspicion and the delayed initiation of treatment. Among the described patients in the literature, 16.6% of patients with prosthetic valve endocarditis died vs. 33% of patients with native valve endocarditis [7]. Echocardiography is essential for diagnosis. It should be performed in all patients with a moderate or high suspicion of infective endocarditis to confirm the diagnosis and guide the timely institution of appropriate therapy, including the need for surgical intervention. It also helps in determining prognosis [10]. Transesophageal echocardiography (TEE) is much more sensitive than transthoracic echocardiography (TTE), with increased diagnostic accuracy. In our case, the diagnosis was easily made without resorting to TEE. It is evident that the outcome of patients with A.baumannii infective endocarditis is poor due to its growing resistance to antimicrobials. Imipenem is usually the first-line antibiotic against infections caused by A. baumannii [7,11], Empirical broad-spectrum therapy (e.g., imipenem/cilastatin) for Acinetobacter infections should be considered in any patient with infective endocarditis when gram-negative coccobacilli are isolated from blood cultures [7]. The present isolate in our patient was resistant to imipenem. No surgical intervention was reported in a study of native-valve endocarditis due to Acinetobacter species [7], and a survival rate of 65% was reported. Our patient met indications for surgical treatment [12], but she was at high risk considering her poor general condition.

Conclusions

This report concluded that native valve infective endocarditis caused by A. baumannii is rare. The relevance of this case is centred on the fact that infective endocarditis due to the dreaded A. baumannii is not a common cause but a possible cause of death in patients who have stayed in the intensive care unit; hence, the necessity of nosocomial infection control and prevention measures.
  12 in total

1.  Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases.

Authors:  J P Gouëllo; P Asfar; O Brenet; A Kouatchet; G Berthelot; P Alquier
Journal:  Crit Care Med       Date:  2000-02       Impact factor: 7.598

2.  Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years.

Authors:  Emanuele Durante-Mangoni; Roberto Andini; Federica Agrusta; Domenico Iossa; Irene Mattucci; Mariano Bernardo; Riccardo Utili
Journal:  Eur J Intern Med       Date:  2014-06-19       Impact factor: 4.487

Review 3.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines.

Authors:  Andrew S Mackie; Wei Liu; Anamaria Savu; Ariane J Marelli; Padma Kaul
Journal:  Can J Cardiol       Date:  2016-02-09       Impact factor: 5.223

5.  Recommendations for the practice of echocardiography in infective endocarditis.

Authors:  Gilbert Habib; Luigi Badano; Christophe Tribouilloy; Isidre Vilacosta; Jose Luis Zamorano; Maurizio Galderisi; Jens-Uwe Voigt; Rosa Sicari; Bernard Cosyns; Kevin Fox; Svend Aakhus
Journal:  Eur J Echocardiogr       Date:  2010-03

6.  Seasonal variation of Acinetobacter infections: 1987-1996. Nosocomial Infections Surveillance System.

Authors:  L C McDonald; S N Banerjee; W R Jarvis
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia.

Authors:  Sang-Ho Choi; Eun Ju Choo; Yee Gyung Kwak; Mi-Young Kim; Jae-Bum Jun; Mi-Na Kim; Nam Joong Kim; Jin-Yong Jeong; Yang Soo Kim; Jun Hee Woo
Journal:  J Infect Chemother       Date:  2007-01-18       Impact factor: 2.211

Review 8.  Infective endocarditis of a native valve due to Acinetobacter: case report and review.

Authors:  J D Gradon; E K Chapnick; L I Lutwick
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

9.  Overview of nosocomial infections caused by gram-negative bacilli.

Authors:  Robert Gaynes; Jonathan R Edwards
Journal:  Clin Infect Dis       Date:  2005-08-16       Impact factor: 9.079

Review 10.  Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features.

Authors:  Saad B Almasaudi
Journal:  Saudi J Biol Sci       Date:  2016-02-11       Impact factor: 4.219

View more
  1 in total

1.  Acinetobacter endocarditis: a rare nosocomial infection of native heart valves.

Authors:  Shervin Shokouhi; Ghodsieh Kamrani; Iman Ghasemzadeh; Mana Baziboroun
Journal:  Iran J Microbiol       Date:  2021-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.